BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang EM, Ma N, Ma T, Zhou JY, Yang WS, Liu CX, Hou ZH, Chen S, Zong Z, Zeng B, Li YR, Zhou TC. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma. World J Gastrointest Oncol 2022; 14(10): 1981-2003 [PMID: 36310708 DOI: 10.4251/wjgo.v14.i10.1981]
URL: https://www.wjgnet.com/1948-5204/full/v14/i10/1981.htm
Number Citing Articles
1
Lin Cheng, Shuhui Li, Deqi Jiang, Rongkai Sun, Yueshan Wang, Jianchao Zhang, Qiang Wei. Decreased levels of PTCSC3 promote the deterioration of prostate cancer and affect the prognostic outcome of patients through sponge miR-182-5pBMC Urology 2024; 24(1) doi: 10.1186/s12894-024-01531-7
2
Jia-qian Mo, Shen-yan Zhang, Qiang Li, Mo-xian Chen, Yue-qing Zheng, Xin Xie, Rongxin Zhang, Shan-shan Wang. Immunomodulation of cuproptosis and ferroptosis in liver cancerCancer Cell International 2024; 24(1) doi: 10.1186/s12935-023-03207-y
3
Mingqin Kuang, Yueyang Liu, Hongxi Chen, Guandi Chen, Tian Gao, Keli You. Big data analysis and machine learning of the role of cuproptosis-related long non-coding RNAs (CuLncs) in the prognosis and immune landscape of ovarian cancerFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1555782
4
Siqi Zhao, Fei Chen, Lingyu Hu, Xiaoping Li, Zhaofeng Gao, Minjie Chen, Xiaoguang Wang, Zhengwei Song. Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for ImmunotherapyFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1523190
5
Yan Li, Shiyu Lv, Yunqiu Wang. Predicting prognosis and drug sensitivity in patients with hepatocellular carcinoma using an lncRNA signature associated with cuproptosisBMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-16132-w
6
Kun Wang, Chunqian Yang, Jingen Xie, Xiao Zhang, Ting Wei, Zhu Yan. Long non-coding RNAs in ferroptosis and cuproptosis impact on prognosis and treatment in hepatocellular carcinomaClinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01397-x
7
Amir Ebrahimi, Tahereh Barati, Zohreh Mirzaei, Fatemeh Fattahi, Sima Mansoori Derakhshan, Mahmoud Shekari Khaniani. An overview on the interaction between non-coding RNAs and CTLA-4 gene in human diseasesMedical Oncology 2024; 42(1) doi: 10.1007/s12032-024-02552-w
8
Shang Rumin, Xiangming Han, Cui Zeng, Fei Lv, Rong Fang, Rongrong Gong, Xiaochang Tian, Xiangwu Ding, Miltiadis Paliouras. Systematic analysis of cuproptosis abnormalities and functional significance in cancerPLOS ONE 2024; 19(4) doi: 10.1371/journal.pone.0300626
9
Daniela Gabbia, Sara De Martin. Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24043441
10
Han Lei, Zhengwei Zhou, Chang Liu, Weiting Chen, Yu Li, Guang Shu, Maonan Wang, Ke Guo, Qiong Pan, Gang Yin. Characterization of Cuproptosis-Related LncRNAs Prognostic Signature and Identification of LINC02285 as a Novel Biomarker for Ovarian CancerJournal of Inflammation Research 2025;  doi: 10.2147/JIR.S521410
11
Pankaj Ahluwalia, Kalyani Ballur, Tiffanie Leeman, Ashutosh Vashisht, Harmanpreet Singh, Nivin Omar, Ashis K. Mondal, Kumar Vaibhav, Babak Baban, Ravindra Kolhe. Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized MedicineCancers 2024; 16(3) doi: 10.3390/cancers16030480
12
Dan Zhang, Siqiao Wei, Qianqiu Wei, Zhansong Lin, Xiaoming Sun. The role of long non-coding RNAs in NK cell biology and diseasesGenes & Diseases 2026; 13(3) doi: 10.1016/j.gendis.2025.101833